Europeiska unionen -
svenska -
EMA (European Medicines Agency)
enspryng
roche registration gmbh - satralizumab - neuromyelitis optica - immunsuppressiva - satralizumab (enspryng) is indicated as a monotherapy or in combination with immunosuppressive therapy (ist) for the treatment of neuromyelitis optica spectrum disorders (nmosd) in adult and adolescent patients from 12 years of age who are anti-aquaporin-4 igg (aqp4-igg) seropositive.
Europeiska unionen -
svenska -
EMA (European Medicines Agency)
kerendia
bayer ag - finerenone - renal insufficiency, chronic; diabetes mellitus, type 2 - agenter som verkar på renin-angiotensinsystemet - kerendia is indicated for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults.
Europeiska unionen -
svenska -
EMA (European Medicines Agency)
vidprevtyn beta
sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - vacciner - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 och 5. 1 in product information document). användning av detta vaccin bör ske i enlighet med officiella rekommendationer.
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
zaditen 0,25 mg/ml ögondroppar, lösning i endosbehållare
laboratoires thea - ketotifenvätefumarat - Ögondroppar, lösning i endosbehållare - 0,25 mg/ml - ketotifenvätefumarat 0,345 mg aktiv substans; glycerol hjälpämne - ketotifen
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
brevibloc 10 mg/ml infusionsvätska, lösning
baxter medical ab - esmololhydroklorid - infusionsvätska, lösning - 10 mg/ml - esmololhydroklorid 10 mg aktiv substans - esmolol
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
cetraxal comp 3 mg/ml + 0,25 mg/ml örondroppar, lösning i endosbehållare
poa pharma scandinavia ab - ciprofloxacinhydroklorid (monohydrat); fluocinolonacetonid - Örondroppar, lösning i endosbehållare - 3 mg/ml + 0,25 mg/ml - ciprofloxacinhydroklorid (monohydrat) 3,49 mg aktiv substans; fluocinolonacetonid 0,25 mg aktiv substans; glycerol hjälpämne